http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9904774-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1491af9959aa74060601cf2daab5339
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66dbcd2aacfc1aaaafd61c42ae7020b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aded8c27121e0f568d0848e7adf88226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88917e78c4ad862d64aa0fb94b6b6ef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab6c2e758447c34e697f3a73b76070f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ed56d691bdc4bccca311dd42f72885d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dae7e6ebf77322ee0e4b99f3395bf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 1998-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bdfe9fc17717ff1c053a6e1a159936a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38a44bae8767dd945c113d0f5f8d629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d05d2c9f7448781384a5275821a58f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63aba482775ebe00e12b8f434756b257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ddf8a6b8b94948153a15932eefb97c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_112401f3517796f06c217eee95f866b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef76af63cbc4431ffd92d0952accc0aa
publicationDate 1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9904774-A3
titleOfInvention Nucleotide analog compositions
abstract The invention provides crystalline forms of adefovir dipivoxil and methods to prepare the crystals. The compositions and methods of the present invention have desirable properties for large scale synthesis of crystalline adefovir dipivoxil or for its formulation into therapeutic dosages. Invention compositions include an anhydrous crystal form of adefovir dipivoxil.
priorityDate 1997-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0632048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0481214-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871

Total number of triples: 43.